74 results
8-K
KRTX
Karuna Therapeutics Inc
14 Mar 24
Other Events
7:26am
. The Merger is expected to close as early as March 18, 2024, subject to satisfaction or waiver of the remaining closing conditions.
Forward-Looking Statements … and conditions for such approvals; the stock price of Karuna prior to the consummation of the proposed transaction; the satisfaction of the closing
8-K
KRTX
Karuna Therapeutics Inc
12 Mar 24
Submission of Matters to a Vote of Security Holders
4:15pm
the proposal to adopt the Merger Agreement.
Assuming timely satisfaction of necessary closing conditions, the parties to the Merger Agreement expect the merger … to the consummation of the proposed transaction; the satisfaction of the closing conditions to the proposed transaction; Karuna’s limited operating history; Karuna’s
DEFA14A
KRTX
Karuna Therapeutics Inc
1 Mar 24
Additional proxy soliciting materials
6:02am
to the consummation of the proposed transaction; the satisfaction of the closing conditions to the proposed transaction; our limited operating history; our
8-K
KRTX
Karuna Therapeutics Inc
1 Mar 24
Other Events
6:01am
, and the timing and conditions for such approvals; the stock price of Karuna prior to the consummation of the proposed transaction; the satisfaction of the closing
DEFM14A
tm6ytmtugwfqwi
5 Feb 24
Proxy related to merger
4:12pm
PREM14A
hcqar
22 Jan 24
Preliminary proxy related to merger
6:05am
DEFA14A
pk54txmvha9y 6g
22 Dec 23
Additional proxy soliciting materials
5:20pm
DEFA14A
a8u5p6
22 Dec 23
Additional proxy soliciting materials
5:20pm
8-K
t52l2y 6y9
22 Dec 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-2.1
qn8 p1yvr8jbbn0
22 Dec 23
Entry into a Material Definitive Agreement
5:07pm
DEFA14A
9d7bp
22 Dec 23
Additional proxy soliciting materials
4:28pm
DEFA14A
uaqoo6edl8xb7bgr5
22 Dec 23
Additional proxy soliciting materials
4:22pm
DEFA14A
pg12yelvr 1b15
22 Dec 23
Additional proxy soliciting materials
4:12pm
DEFA14A
37h7hg vkj1
22 Dec 23
Additional proxy soliciting materials
8:31am
8-K
4fjfzyec
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
8:26am